• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

    6/8/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABT alert in real time by email
    • Study at ADA's Scientific Sessions shows participants in Abbott's Healthy Food Rx program combined with health coaching had significant health improvements
    • Abbott's Healthy Food Rx program is a Food is Medicine initiative delivering recipe-based food boxes and nutrition education to people living with diabetes

    NEW ORLEANS, June 8, 2026 /PRNewswire/ -- New research presented at the American Diabetes Association's 86th Scientific Sessions showed that adults living with type 2 diabetes participating in Abbott's (NYSE:ABT) Healthy Food Rx "Food is Medicine" program, paired with community health worker–led coaching, experienced major improvements in healthy eating, physical activity, diabetes self-management, food insecurity and self-reported physical and mental health.

    Abbott Logo

    Conducted with the Public Health Institute Center for Wellness and Nutrition (PHI CWN), the Asian Pacific Self-Development and Residential Association (APSARA) and the Emergency Food Bank of Stockton/San Joaquin (EFB), and with funding from Abbott's philanthropic foundation Abbott Fund, the study assessed 284 participants living with type 2 diabetes who received Healthy Food Rx food boxes alongside community health worker–led coaching over a six-month period.

    Key findings from the study revealed:

    • Improved diet quality: Participants doubled daily vegetable intake (from 1.2 to 2.4 times per day) and nearly doubled daily fruit intake (from 1.2 to 2.3 times per day). Water intake also increased from 2.8 to 4.1 times per day.
    • Increased physical activity: Participants significantly increased the frequency of exercise sessions lasting 10 or more minutes from 2.8 to 4.4 times per week.
    • Stronger diabetes self-management: Participants significantly improved glucose monitoring, medication adherence and clinic attendance. Notably, the percentage of participants who reported they usually or always monitored their glucose increased from 28% to 62%, and individuals who usually or always took their diabetes medication as prescribed increased from 57% to 94%.
    • Better physical and mental health: Those reporting good, very good or excellent physical health more than tripled from 21% to 77%, and those reporting good, very good or excellent mental health more than doubled from 34% to 88%.
    • Reduced food insecurity: Food insecurity decreased significantly from 91% to 76% for program participants.

    "This research adds to the evidence supporting Food is Medicine and adds new insight on the significant impact that community-centered approaches can have on diabetes care," said Maggie Wilkin, director of research and evaluation, Public Health Institute Center for Wellness and Nutrition. "These findings show that pairing healthy food access with culturally responsive, patient-centered coaching can help people feel better physically and mentally."

    "Abbott's Healthy Food Rx program shows what's possible when people receive not only healthy food, but also encouragement and coaching from someone they trust who understands their daily realities," said Melissa Brotz, senior vice president, Global Marketing and External Affairs, Abbott and president of Abbott Fund. "Food is Medicine is most powerful when it combines healthy food access with the knowledge, confidence and support people need to manage their health."

    "Many people with diabetes face real-world challenges in getting the care and support they need to live healthy. Community health workers can play a powerful role in helping people manage chronic illness because they bring trust, understanding and consistency to the work," said David Daraseng, project coordinator, APSARA.

    About the study 

    Study participants received home-delivered, family-sized healthy food boxes every other week for six months from EFB, along with health coaching in their preferred language from APSARA. Each Healthy Food Rx box included ingredients for healthy family meals such as pantry staples, proteins, fruits and vegetables, along with a recipe card and access to optional online cooking classes with diabetes education. Community health workers co-created and delivered monthly lessons and conducted twice-monthly follow-ups to support goal setting, motivation and diabetes self-management.

    The study evaluation was conducted over two six-month rounds, examining changes in diet, physical activity, food security, diabetes self-management and self-reported health before and after participation. Full study results can be found here.

    About Abbott's Healthy Food Rx

    These findings build on results from other Healthy Food Rx studies. An earlier 12-month study showed clinically significant improvements for participants, with lower A1C levels and improved  diabetes self-management, overall diet quality and food security, and a randomized controlled trial demonstrated improved diet and self-reported health among participants.

    Abbott's Healthy Food Rx is one of the largest community-focused Food is Medicine programs in the U.S., reaching 2,100 participants to date. Abbott partnered with PHI CWN and Stockton-based organizations to launch Healthy Food Rx with funding from Abbott Fund.

    Healthy Food Rx is part of Abbott's Future Well™ Communities program, a multi-year effort launched in 2019 to advance health access and address chronic disease by removing barriers that prevent people from living fuller lives through better health.

    About the Public Health Institute and the Center for Wellness and Nutrition 

    The Public Health Institute, an independent nonprofit organization, advances wellbeing and health equity with communities around the world. PHI develops research, leadership and partnerships to build strong public health policy, programs, systems and practices. For more information, visit phi.org. The Center for Wellness and Nutrition (CWN, centerforwellnessandnutrition.org), a program of the Public Health Institute, is a national leader in developing campaigns, programs and partnerships to promote wellness and equitable practices in the most vulnerable communities in California and across the country.

    About APSARA

    The Asian Pacific Self-Development and Residential Association (APSARA) is a grassroots nonprofit community-based organization serving Stockton, CA communities, with a focus on Southeast Asian populations as well as African American and Latino residents. APSARA provides community-based education, case management and support services that help individuals and families improve health and wellbeing.

    About the Emergency Food Bank of Stockton/San Joaquin

    The Emergency Food Bank Stockton/San Joaquin (EFB), founded in 1968, is the largest direct provider of emergency food in San Joaquin County. The mission of the Emergency Food Bank is to build a stronger community by providing a safety net of healthy food, nutrition education and hope to residents of San Joaquin County who find themselves in need. For more information, visit stocktonfoodbank.org.

    About Abbott and Abbott Fund 

    Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 122,000 colleagues serve people in more than 160 countries. Together with our foundation, Abbott Fund, we partner with trusted organizations to build programs that strengthen care, improve access and help families and communities thrive. We're committed to building a healthier future by inspiring lifelong habits that support well-being and help to prevent chronic disease for generations to come. Connect with us at Abbott.com and on LinkedIn, Facebook, Instagram, X and YouTube.

    Cision View original content:https://www.prnewswire.com/news-releases/new-research-shows-even-stronger-health-outcomes-for-participants-in-a-food-is-medicine-program-when-paired-with-support-from-community-health-workers-302793406.html

    SOURCE Abbott

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT

    DatePrice TargetRatingAnalyst
    4/22/2026$92.00Outperform → Neutral
    Daiwa Securities
    10/10/2025$145.00Buy
    The Benchmark Company
    7/18/2025$145.00Hold → Buy
    Jefferies
    6/16/2025$143.00Market Perform
    Leerink Partners
    10/8/2024$130.00Outperform
    Oppenheimer
    9/19/2024$131.00Overweight
    Piper Sandler
    7/30/2024Buy → Hold
    Edward Jones
    5/30/2024$121.00Buy
    Goldman
    More analyst ratings

    $ABT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Abbott Labs downgraded by Daiwa Securities with a new price target

    Daiwa Securities downgraded Abbott Labs from Outperform to Neutral and set a new price target of $92.00

    4/22/26 7:52:11 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Benchmark Company initiated coverage on Abbott Labs with a new price target

    The Benchmark Company initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $145.00

    10/10/25 8:35:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott Labs upgraded by Jefferies with a new price target

    Jefferies upgraded Abbott Labs from Hold to Buy and set a new price target of $145.00

    7/18/25 7:54:43 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers

    Study at ADA's Scientific Sessions shows participants in Abbott's Healthy Food Rx program combined with health coaching had significant health improvementsAbbott's Healthy Food Rx program is a Food is Medicine initiative delivering recipe-based food boxes and nutrition education to people living with diabetesNEW ORLEANS, June 8, 2026 /PRNewswire/ -- New research presented at the American Diabetes Association's 86th Scientific Sessions showed that adults living with type 2 diabetes participating in Abbott's (NYSE:ABT) Healthy Food Rx "Food is Medicine" program, paired with community health worker–led coaching, experienced major improvements in healthy eating, physical activity, diabetes self-

    6/8/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

    Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may contribute to missed warning signs of DKA and delays in interventionNearly 60% of pediatric hospitalizations for Type 1 diabetes in the U.S. are associated with DKA1ABBOTT PARK, Ill., June 6, 2026 /PRNewswire/ -- Abbott (NYSE:ABT), the global healthcare leader, announced new data revealing diabetic ketoacidosis (DKA) remains an important, yet often undetected health concern for people living with both Type 1 and Type 2 diabetes. Findings from multiple Abbott studies shared at the American Diabetes Association's (ADA) June 2026 86th Scientific

    6/6/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott secures CE Mark for world's first dual glucose-ketone sensing technology for people with diabetes

    First-of-its-kind biowearables combine continuous glucose and ketone monitoring in a single sensor to support both daily diabetes management and help detect rising ketone levels that can lead to diabetic ketoacidosis, a serious health condition for people with diabetesIntegrates with the Libre digital health ecosystem, allowing people to share glucose and ketone data with caregivers and healthcare providersDesigned for compatibility with leading automated insulin delivery (AID) systemsABBOTT PARK, Ill., May 27, 2026 /PRNewswire/ -- Abbott (NYSE:ABT), a global healthcare leader, announced today it has secured CE Mark for the world's first dual glucose‑ketone sensing technology for people with

    5/27/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Starks Daniel J bought $926,537 worth of Common shares without par value (10,000 units at $92.65) and was granted 2,286 units of Common shares without par value, increasing direct ownership by 0.18% to 6,751,103 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    4/28/26 7:37:56 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EVP AND CFO Boudreau Philip P bought $201,300 worth of Common shares without par value (2,200 units at $91.50) (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    4/27/26 5:34:47 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Starks Daniel J bought $1,087,331 worth of Common shares without par value (10,000 units at $108.73), increasing direct ownership by 0.15% to 6,738,817 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    2/6/26 8:04:16 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    SEC Filings

    View All

    SEC Form SD filed by Abbott Laboratories

    SD - ABBOTT LABORATORIES (0000001800) (Filer)

    5/27/26 4:47:43 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Abbott Laboratories

    SCHEDULE 13G - ABBOTT LABORATORIES (0000001800) (Subject)

    4/29/26 4:42:23 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Abbott Laboratories

    10-Q - ABBOTT LABORATORIES (0000001800) (Filer)

    4/29/26 4:05:05 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Leadership Updates

    Live Leadership Updates

    View All

    Abbott HeartMates Community Delivers Holiday Cheer in Hallmark Channel's New Movie "The More the Merrier"

    Movie to feature cameos from youth who have overcome significant heart health challenges and are part of the Abbott HeartMates community as well as professional football player and HeartMates ambassador Damar Hamlin "The More the Merrier" is the first Hallmark movie ever to include cameos from real-life individuals who have overcome cardiovascular challengesCharacter in the movie was inspired by Abbott HeartMates member Zeke Mankins, who has established a friendship with Hamlin through Hamlin's ambassador role for the HeartMates communityMovie premieres on Hallmark Channel on Nov. 28, 2025, during Hallmark's Merry Thanksgiving Weekend during "Countdown to Christmas"ABBOTT PARK, Ill., Nov. 4,

    11/4/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent

    This summer, Abbott and Real Madrid are hosting tryouts across the U.S. to form the 'Abbott Dream Team'Tryout attendees will learn about health and sports nutrition, encouraging them to promote healthy habits and an active lifestyle in their communitiesEleven selected players will travel to Madrid, train at Real Madrid's world-class facilities, and be instructed by Real Madrid coachesAmerican soccer icon Clint Dempsey will mentor the athletes throughout their journeyABBOTT PARK, Ill., May 7, 2025 /PRNewswire/ -- Abbott (NYSE:ABT) announced today the creation of the inaugural 'Abbott Dream Team.' The program will seek out talented soccer players from across the United States and give them a o

    5/7/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Drive Growth and Market Expansion

    Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the appointment of Paul Wilson as Chief Commercial Officer (CCO). In this role, Mr. Wilson will lead the company's commercial strategy, overseeing sales, marketing, clinical programming, and business development initiatives. His leadership will help expand awareness, accelerate growth, and strengthen market positioning of Cagent Vascular's proprietary serration balloon technology. Mr. Wilson brings many years of experience in the medical device industry, having held senior commercial leadership positions at Teleflex (NYSE:TFX) and Abbott (NYSE:ABT). With

    3/4/25 11:38:00 AM ET
    $ABT
    $TFX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Dental Instruments

    $ABT
    Financials

    Live finance-specific insights

    View All

    Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

    First-quarter GAAP diluted EPS of $0.61; adjusted diluted EPS of $1.15 reflects growth of 6 percentCompleted acquisition of Exact Sciences, establishing Abbott as a leader in the fast-growing oncology diagnostics marketAbbott projects full-year 2026 comparable sales growth of 6.5% to 7.5%1Abbott projects full-year 2026 adjusted diluted EPS of $5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact SciencesABBOTT PARK, Ill., April 16, 2026 /PRNewswire/ -- Abbott today (NYSE:ABT) announced financial results for the first quarter ended March 31, 2026. First-quarter sales increased 7.8 percent on a reported basis and 3.7 percent on a comparable basis.First-quarter GA

    4/16/26 7:30:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott hosts conference call for first-quarter earnings

    ABBOTT PARK, Ill., March 26, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its first-quarter 2026 financial results on Thursday, April 16, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.About Abbott: Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical

    3/26/26 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Abbott completes acquisition of Exact Sciences

    Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segmentsAdvances Abbott's mission to make healthcare more accessible and give people more control over their healthABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE:ABT) today announced it has completed the acquisition of Exact Sciences, establishing Abbott as a leader in fast-growing cancer screening and diagnostics segments and enabling the company to serve millions of additional people. "Abbott's global scale, track record of operational and commercial excellence and work with healthcare systems around the world will expand access to important tools for early cancer detection and personalized trea

    3/23/26 8:50:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/13/24 4:55:58 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/9/23 10:54:50 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Abbott Laboratories (Amendment)

    SC 13G/A - ABBOTT LABORATORIES (0000001800) (Subject)

    2/9/22 3:15:56 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by EXECUTIVE VICE PRESIDENT Moreland Mary K

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    4/29/26 5:09:00 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Conroy Kevin T was granted 2,286 units of Common shares without par value, increasing direct ownership by 2% to 133,737 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    4/28/26 8:07:28 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Conroy Kevin T claimed ownership of 131,451 units of Common shares without par value (SEC Form 3)

    3 - ABBOTT LABORATORIES (0000001800) (Issuer)

    4/28/26 7:58:34 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care